Coalition-based approaches for addressing environmental issues in childhood asthma
Elisa A Nicholas1, Maura Dwyer, Amy Murphy
1Long Beach Alliance for Children with Asthma (LBACA), The Children's Clinic, Serving Children and Their Families in Long Beach, CA, USA.
Health Promotion Practice
|April 26, 2006
Summary
Childhood asthma is worsened by indoor and outdoor air pollution. Community coalitions worked to reduce exposure through education, remediation, and policy changes, highlighting the importance of partnerships for success.
Area of Science:
- Environmental Health
- Pediatric Respiratory Medicine
- Public Health Policy
Background:
- Childhood asthma is frequently exacerbated by indoor and outdoor environmental triggers.
- Exposure to air pollution in both home and school environments poses significant risks.
- Existing interventions often face challenges related to housing affordability and policy reform.
Purpose of the Study:
- To describe the strategies employed by Allies Against Asthma coalitions to mitigate childhood asthma triggers.
- To identify key factors contributing to the success of asthma environmental intervention programs.
- To explore the challenges encountered during the implementation of these initiatives.
Main Methods:
- Coalition-based interventions focused on indoor trigger education and remediation.
- Healthcare provider education on environmental asthma triggers.
- Policy advocacy for improved indoor and outdoor air quality in homes and schools.
- Public awareness campaigns regarding environmental asthma triggers.
Main Results:
- Interventions included education, trigger remediation, and policy efforts targeting indoor and outdoor asthma triggers.
- Successful implementation was contingent upon addressing housing barriers and resource allocation for policy change.
- Coordination, partnerships, consistent messaging, and a unified voice were crucial for policy success.
Conclusions:
- Collaborative, multi-faceted approaches are effective in reducing childhood asthma triggers.
- Addressing systemic issues like housing and policy is essential for comprehensive asthma management.
- Strong partnerships and advocacy are vital for improving children's environmental health and asthma outcomes.
Related Concept Videos
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

